Your browser doesn't support javascript.
loading
The Challenge of Adherence to a Complex Antiretroviral Therapy Regimen in an Individual With Multidrug-Resistant HIV.
Moretti, Marco; Stoffels, Karolien; Van Laethem, Kristel; Verhofstede, Chris; Van Den Wijngaert, Sigi; Martin, Charlotte.
Afiliação
  • Moretti M; Vrije Universiteit Brussel (VUB), Universitair ziekenhuis Brussel (UZB), Belgium; Université Libre de Bruxelles (ULB).
  • Stoffels K; Centre Hospitalier Universitaire Saint-Pierre, Brussels, Belgium.
  • Van Laethem K; Rega Institute for Medical Research, KU Leuven, Belgium; University Hospitals Leuven, Belgium.
  • Verhofstede C; Ghent University, Belgium.
  • Van Den Wijngaert S; Centre Hospitalier Universitaire Saint-Pierre, Brussels, Belgium.
  • Martin C; Université Libre de Bruxelles (ULB), Belgium.
Top Antivir Med ; 32(2): 437-444, 2024 Apr 18.
Article em En | MEDLINE | ID: mdl-39141922
ABSTRACT
Limited therapeutic options are available for patients with multidrug-resistant HIV. This report describes a 38-year-old female who was perinatally infected with HIV-1 and treated with 14 different antiretroviral regimens over 27 years, gradually leading to 4-class drug resistance. Despite various attempts to obtain sustained viral suppression, including the off-label administration of intravenous foscarnet and enfuvirtide, and thorough follow-up with 16 viral genotyping/phenotyping from 1999 to 2021, viral control was not maintained. Recently, the introduction of a regimen with fostemsavir and lenacapavir resulted in long-term viral suppression.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções por HIV / HIV-1 / Fármacos Anti-HIV / Farmacorresistência Viral Múltipla Limite: Adult / Female / Humans Idioma: En Revista: Top Antivir Med Ano de publicação: 2024 Tipo de documento: Article País de publicação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções por HIV / HIV-1 / Fármacos Anti-HIV / Farmacorresistência Viral Múltipla Limite: Adult / Female / Humans Idioma: En Revista: Top Antivir Med Ano de publicação: 2024 Tipo de documento: Article País de publicação: Estados Unidos